NY-ESO-1 Protein Vaccine Combining Alum, CpG ODN, and HH2 Complex Adjuvant Induces Protective and Therapeutic Anti-Tumor Responses in Murine Multiple Myeloma

Overview of attention for article published in OncoTargets and therapy, August 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 5 publications that cite this research output.

5

The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.

Advances, opportunities and challenges in developing therapeutic cancer vaccines

Article in Critical Reviews in Oncology/Hematology (November 2023)

Montanide ISA-720 and Naloxone in HBsAg Vaccine Formulation: Cytokine Profiling and Monitoring of Long-Lasting Humoral Immune Responses

Article in Biomedical and Environmental Sciences (September 2022)

Chapter 3 Tumor antigens for preventative cancer vaccines

Book chapter (January 2022)